Results 261 to 270 of about 98,500 (300)

Patients with chronic kidney disease stage 3b: do general practitioners and nephrologists follow KDIGO guidelines? [PDF]

J Bras Nefrol
Macedo JG, Almeida AM, Sanders-Pinheiro H, Fabreti-Oliveira RA.   +3 more
europepmc   +1 more source

Improvement of Health‐Related Quality of Life and Mental Health After Unilateral Adrenalectomy for Primary Aldosteronism

Clinical Endocrinology, Volume 105, Issue 1, Page 24-33, July 2026.
ABSTRACT Background Primary aldosteronism (PA) has been linked with reduced health‐related quality of life (QoL) and increased prevalence of anxiety and depression. While most studies compared patients with PA to healthy subjects, this study focused on comparison with hypertensive patients without PA to identify PA‐specific effects.
Sybille Fuld, Christian Adolf, Georgiana Constantinescu, Manuel Schulze, Denise Brüdgam, Carmina T. Fuss, Hanna Remde, Lydia Kürzinger, Sven Gruber, Jun Yang, Amy Kang, Martin Reincke, Felix Beuschlein, Graeme Eisenhofer, Jacques W. M. Lenders, Christina Pamporaki   +15 more
wiley   +1 more source

Dynamics and Predictive Values of Urinary Podocyte Biomarkers Following SGLT2 Inhibition in CKD. [PDF]

Life (Basel)
Urs A, Moldovan D, Rusu CC, Bondor CI, Potra AR, Tirinescu D, Țicală M, Maslyennikov Y, Bărar AA, Dînșoreanu I, Kacso IM.   +10 more
europepmc   +1 more source

Incidence, Progression and Determinants of Diabetic Retinopathy in Type 2 Diabetes in Australasia: A Systematic Review and Meta‐Analysis

Clinical &Experimental Ophthalmology, Volume 54, Issue 4, Page 460-481, May/June 2026.
ABSTRACT Background Current evidence on incidence and progression rate of diabetic retinopathy reveals disparities across Australasia, and no pooled estimates are available to guide region‐wide planning. This review and meta‐analysis assesses the overall incidence, determinants and progression of diabetic retinopathy in Australasia.
Getasew Alemu Mersha, Mesert Derbew Molla, Ranjay Chakraborty, Georgia Kaidonis, Stewart Lake, Jamie Craig, José Estevez   +6 more
wiley   +1 more source

Impact of Renal Disease Markers on Cardiovascular Disease Risk Prediction When Coronary Calcium Score Is Known. [PDF]

J Am Heart Assoc
Barzilay J, Trujillo R, Hansen S, Blaha M, Budoff M, McClelland RL.   +5 more
europepmc   +1 more source

Heterogeneous Kidney Patterns in Diabetic Patients Following SGLT2 Inhibitor Use. [PDF]

J Korean Med Sci
Bae S, Yun D, Kim J, Park S, Kim YC, Kim DK, Oh KH, Joo KW, Kim YS, Han SS.   +9 more
europepmc   +1 more source

Sodium-Glucose Cotransporter-2 Inhibitors in CKD: Is it Time to Update the Guideline Recommendations for Broader Cardiorenal Protection? [PDF]

Kidney Int Rep
Georgianos PI, Vaios V, Roumeliotis A, Liakopoulos V.   +3 more
europepmc   +1 more source

Detection of vascular amyloid deposits in a bone marrow aspirate

British Journal of Haematology, EarlyView.
Konstantinos Liapis, Georgios Kanellis, Georgios Vrachiolias, Evangelia Charitaki   +3 more
wiley   +1 more source

Diabetic kidney disease in northwest Ethiopia: Prevalence and determinants among adults with type 2 diabetes. [PDF]

PLoS One
Hailu W, Dejene TA, Tiruneh M, Molla MD, Birru EM, Alemu S, Awoke T.   +6 more
europepmc   +1 more source